Welcome to our dedicated page for GoodRx Holdings news (Ticker: $GDRX), a resource for investors and traders seeking the latest updates and insights on GoodRx Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GoodRx Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GoodRx Holdings's position in the market.
Rhea-AI Summary
GoodRx Holdings, Inc. (Nasdaq: GDRX) reported preliminary unaudited financial results for Q4 and full year 2023. Q4 Revenue expected to be $195-197 million, a 6-7% increase YoY. Full year 2023 Revenue expected to be $749-751 million, a 2% decrease YoY. Adjusted EBITDA Margins expected to be at the upper end of previous guidance range. The increase in revenue was primarily driven by organic growth in Prescription Transactions Revenue.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.31%
Tags
-
Rhea-AI Summary
GoodRx (Nasdaq: GDRX) appoints Kelly J. Kennedy, former CFO of The Honest Company, to its Board of Directors, bringing over 25 years of experience in retail and consumer brands. Kennedy will serve on the audit committee, leveraging her expertise in risk assessment management and financial reporting. She currently serves as CFO for Willow Innovations and has previously held CFO positions at The Bartell Drug Company and The Honest Company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.62%
Tags
-
Rhea-AI Summary
GoodRx Holdings, Inc. (Nasdaq: GDRX) executives will participate in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024. The live webcast will be available on the Company's Investor Relations website, with an archived recording available for at least 30 days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.62%
Tags
Rhea-AI Summary
Amino Health (AMNO), a leading digital healthcare navigation company, announced the appointment of John Asalone as the new CEO, succeeding founder and former CEO David Vivero. Asalone, a seasoned executive with 20 years of experience scaling software and marketplace companies, aims to bring consumer-grade experiences to healthcare. Amino has secured $80 million in financing, paving the way for future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.29%
Tags
-
Rhea-AI Summary
Datassential's former CEO, Jim Emling, has been appointed Executive Chair of the Board of Directors at VBA, a company heavily investing in sales and product development after closing a growth equity transaction led by Spectrum Equity and Arthur Ventures. VBA serves the entire payer landscape, including third party administrators (TPAs) and health plans, with its next-gen Core Administrative Processing System, user engagement platforms, customer support tools, population health reporting solution, and robust data connections.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
GoodRx Holdings, Inc. (Nasdaq: GDRX) executives will participate in a fireside chat at the Evercore ISI HealthCONx Conference in Miami, FL on November 30, 2023. The live webcast will be available on the Company's Investor Relations website, with an archived recording available for at least 30 days. This event aims to provide valuable insights into the company's position in the healthcare industry and its future prospects.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.58%
Tags
Rhea-AI Summary
GDRX - GoodRx Holdings, Inc. Releases Q3 2023 Financial Results, Reports Revenue of $180.0M, Net Loss of $38.5M, and Over 550,000 Prescribers Engaged. Anticipates 4Q 2023 Revenue of $188-$194M and Adjusted EBITDA Margin in Mid-to-High Twenty-Percent Range
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.83%
Tags
-
Rhea-AI Summary
GoodRx partners with Sanofi to offer affordable access to Lantus insulin for people with diabetes
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
-
Rhea-AI Summary
GoodRx Holdings, Inc. will release its Q3 2023 financial results on November 9, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.03%
Tags
Rhea-AI Summary
GoodRx and Navitus Health Solutions launch Savings Connect program for automatic access to GoodRx prices on generic drugs
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.88%
Tags
GoodRx Holdings, Inc.
Nasdaq:GDRX
GDRX Rankings
GDRX Stock Data
2.50B
83.53M
11.89%
61.61%
2.34%
Data Processing, Hosting, and Related Services
Information
United States of America
SANTA MONICA
About GDRX
goodrx helps americans save on prescriptions. americans spend over $400 billion a year on prescriptions, and too many people simply can't find affordable prescriptions. even if you have insurance or medicare. we offer a website and mobile apps that gathers current prices, powerful savings tips and valuable discounts for every prescription drug at virtually every pharmacy in the us. goodrx is used by thousands of physicians and millions of americans each month. we have saved americans over $3 billion. we're not going to rest until prescriptions are affordable for all americans. we also offer goodrx for benefits, which provides technology solutions for health plans, payors and pbm's in an easy-to-understand website and mobile app experience. learn more at www.goodrx.com/benefits.